加拿大不列颠哥伦比亚省癌病署的研究人员同温哥华一家名为KinetekPharmaceuticals的制药厂合作,成功研制出一种抗癌新药。癌病署的戴德哈医生说,在癌细胞中有一种名为ILK的基因,另外一种可使它突然消失的基因不存在时,它就会变得特别活跃。研究出的新药,将会取代那种能抑制ILK Researchers from British Columbia’s Cancer Institute in Canada have successfully developed a new anti-cancer drug in collaboration with a Vancouver-based pharmaceutical company called Kinetek Pharmaceuticals. Dr Dahkah of the Oncology Department said that there is a gene called ILK in cancer cells, and another gene that suddenly disappears in the absence of it will become particularly active. New drugs developed will replace those that can inhibit ILK